COME ON MEMBERS, TIME TO CALL THE CITY COUNCIL, GO TO THE OUR "ACT NOW" PAGE
YOU ARE ON OUR NEWEST PAGE: "MEDICARE"
NO NOT THE MEDICARE ADVANTAGE PAGE-JUST PLAIN MEDICARE!
YOU SHOULD HAVE BY NOW RECEIVED YOUR "MEDICARE & YOU 2023" INFORMATIONAL BOOKLET IN THE MAIL. BELOW ARE SOME OF THE MAJOR POINTS OF THE BOOKLET. FOR ANYTHING DEALING WITH MEDICARE ADVANTAGE-THIS ISSUE IS STILL IN LIMBO. IT'S UP TO US TO STOP ANY POLITICIAN FROM STEALING OUR DEFINED BENEFIT. GO TO THE "ACT NOW" PAGE BY CLICKING ON "FIND OUT MORE" FOR MORE ON HOW TO PROTECT OUR HEALTHCARE-THANK YOU FOR YOUR SUPPORT!
~2023 Medicare Costs~
2023 Part B deductible—$226 before Original Medicare starts to pay.
Medicare Part A (Hospital Insurance) Costs
Part A monthly premium-
Most people don’t pay a Part A premium because they paid Medicare taxes while working. If you don’t get premium-free Part A, you pay up to $506 each month. If you don’t buy Part A when you’re first eligible for Medicare (usually when you turn 65), you might pay a penalty.
Hospital stay In 2023, you pay:
■ $1,600 deductible per benefit period
■ $0 for the first 60 days of each benefit period
■ $400 per day for days 61–90 of each benefit period
■ $800 per “lifetime reserve day” after day 90 of each benefit period (up to a maximum of 60 days over your lifetime)
Skilled Nursing Facility stay In 2023, you pay:
■ $0 for the first 20 days of each benefit period ■ $200 per day for days 21–100 of each benefit period
■ All costs for each day after day 100 of the benefit period
Medicare Part B (Medical Insurance) Costs
Part B monthly premium-
Most people pay the standard Part B monthly premium amount ($164.90 in 2023). Social Security will tell you the exact amount you’ll pay for Part B in 2023.
You pay the standard premium amount if you:
■ Enroll in Part B for the first time in 2023.
■ Don’t get Social Security benefits.
■ Are directly billed for your Part B premiums.
■ Have Medicare and Medicaid, and Medicaid pays your premiums. (Your state will pay the standard premium amount of $164.90 in 2023.)
MEDICARE LINKS
Medicare will pay for Alzheimer's Drug; Leqembi
What Patients & Doctors Should Know
Summary:
- Medicare is now covering Leqembi, the only Alzheimer's treatment on the market that slowed cognitive decline in early stages of the disease in a clinical trial.
- Although Medicare will pick up a majority of the bill, patients could still pay more than $5,000 in out-of-pocket costs.
- Those out-of-pocket costs could prove unaffordable for many people, particularly Black and Hispanic patients who are at higher risk of Alzheimer's disease.
- Medicare has agreed to pay for the Alzheimer's treatment Leqembi, a major turning point for patients who are diagnosed with the early stages of the disease.
Details:
Leqembi is the only drug on the market right now that has demonstrated the ability to slow the progression of early stages of Alzheimer's disease in a clinical trial. The monoclonal antibody, administered twice monthly through intravenous means, slowed cognitive decline by 27% over 18 months in the trial.
Leqembi is made by Japanese drugmaker Eisai and its partner Biogen, which is based in Cambridge, Massachusetts.
Medicare's decision to cover Leqembi, which came moments after the Food and Drug Administration fully approved the drug Thursday, promises to make the treatment more accessible to patients.
Medicare coverage is crucial for most patients to have any hope of being able to afford Leqembi. Eisai has priced Leqembi at $26,500 per year before insurance coverage, which is extraordinarily expensive for Medicare patients, who have a median income of about $30,000.
Medicare is picking up the majority of the bill, though many patients will still face several thousand dollars in out-of-pocket costs.
Patients with traditional Medicare will pay 20% of the bill for Leqembi, according to the federal Centers for Medicare and Medicaid Services. That means these patients could see an annual bill of more than $5,000, according to an estimate from KFF, a nonprofit group that researches health-care issues.
People with Medicare Advantage plans also typically pay 20% for drugs such as Leqembi, up to their out-of-pocket maximum, which was about $5,000 on average for in-network services, according to KFF.
Patients with supplemental insurance such as Medigap or Medicaid might pay less, according to KFF.
People of modest means might not be able to afford the out-of-pocket costs for Leqembi even with Medicare coverage, said Tricia Neuman, an expert on Medicare at KFF.
TO READ THE WHOLE ARTICLE, click> Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know (msn.com)
,